{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T20:27:31Z","timestamp":1767904051069,"version":"3.49.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.pupt.2021.102033","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T13:59:06Z","timestamp":1619099946000},"page":"102033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Treatment of pulmonary hypertension in patients with Hereditary Hemorrhagic Telangiectasia \u2013 A case series and systematic review"],"prefix":"10.1016","volume":"68","author":[{"given":"Eric","family":"Abston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0390-8407","authenticated-orcid":false,"given":"Stephanie","family":"Hon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josanna","family":"Rodriguez-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matt","family":"Moll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lanuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harrison W.","family":"Farber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin C.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2021.102033_bib1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/(SICI)1096-8628(19980319)76:3<269::AID-AJMG12>3.0.CO;2-F","article-title":"Report on the workshop on hereditary hemorrhagic telangiectasia, july 10-11, 1997","volume":"76","author":"Marchuk","year":"1998","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.pupt.2021.102033_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng1294-345","article-title":"Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1","volume":"8","author":"McAllister","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.pupt.2021.102033_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1086\/513903","article-title":"The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2","volume":"61","author":"Berg","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.pupt.2021.102033_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jmg.2009.069013","article-title":"International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia","volume":"48","author":"Faughnan","year":"2011","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.pupt.2021.102033_bib5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","article-title":"Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)","volume":"91","author":"Shovlin","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.pupt.2021.102033_bib6","doi-asserted-by":"crossref","DOI":"10.7326\/M20-1443","article-title":"Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia","author":"Faughnan","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.pupt.2021.102033_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19103203","article-title":"Pulmonary arterial hypertension and hereditary haemorrhagic telangiectasia","volume":"19","author":"Vorselaars","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pupt.2021.102033_bib8","first-page":"1","article-title":"Pulmonary arteriovenous fistulae","volume":"28","author":"Le Roux","year":"1959","journal-title":"Q. J. Med."},{"key":"10.1016\/j.pupt.2021.102033_bib9","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/hrt.31.5.559","article-title":"Pulmonary hypertension in patients with pulmonary arteriovenous fistulae","volume":"31","author":"Sapru","year":"1969","journal-title":"Br. Heart J."},{"key":"10.1016\/j.pupt.2021.102033_bib10","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000458447","article-title":"Pulmonary hypertension in a large cohort with hereditary hemorrhagic telangiectasia","volume":"94","author":"Vorselaars","year":"2017","journal-title":"Respiration"},{"key":"10.1016\/j.pupt.2021.102033_bib11","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1164\/rccm.201702-0267LE","article-title":"Pulmonary hypertension prevalence and prognosis in a cohort of patients with hereditary hemorrhagic telangiectasia undergoing embolization of pulmonary arteriovenous malformations","volume":"196","author":"Chizinga","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2021.102033_bib12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/1358863X18767761","article-title":"Life expectancy and comorbidities in patients with hereditary hemorrhagic telangiectasia","volume":"23","author":"Droege","year":"2018","journal-title":"Vasc. Med."},{"key":"10.1016\/j.pupt.2021.102033_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/2045894018759918","article-title":"The clinical characteristics and long-term prognosis of pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia","volume":"8","author":"Li","year":"2018","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.pupt.2021.102033_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Galie","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.pupt.2021.102033_bib15","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/CIRCULATIONAHA.109.192230","volume":"119","author":"McLaughlin","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.pupt.2021.102033_bib16","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0055-2016","article-title":"Epoprostenol and pulmonary arterial hypertension: 20 years of clinical experience","volume":"26","author":"Sitbon","year":"2017","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.pupt.2021.102033_bib17","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1017\/S1047951118001531","article-title":"Paediatric pulmonary hypertension caused by an ACVRL1 mutation presenting as Ortner syndrome","volume":"28","author":"Alsheikh","year":"2018","journal-title":"Cardiol. Young"},{"key":"10.1016\/j.pupt.2021.102033_bib18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/01.CIR.0000153798.78540.87","article-title":"Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood","volume":"111","author":"Harrison","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pupt.2021.102033_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/thx.2007.076109","article-title":"Early-life pulmonary arterial hypertension with subsequent development of diffuse pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia type 1","volume":"63","author":"Mache","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2021.102033_bib20","doi-asserted-by":"crossref","first-page":"E364","DOI":"10.1111\/j.1399-3046.2012.01717.x","article-title":"Bilateral lung transplant for hereditary hemorrhagic telangiectasia in a pediatric patient","volume":"16","author":"Misra","year":"2012","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.pupt.2021.102033_bib21","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/adc.2007.133082","article-title":"Clinical features of pulmonary arterial hypertension in young people with an ALK1 mutation and hereditary haemorrhagic telangiectasia","volume":"94","author":"Smoot","year":"2009","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.pupt.2021.102033_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12890-016-0183-7","article-title":"Novel homozygous BMP9 nonsense mutation causes pulmonary arterial hypertension: a case report","volume":"16","author":"Wang","year":"2016","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.pupt.2021.102033_bib23","series-title":"A Case of Pulmonary Arterial Hypertension Secondary to Hereditary Hemorrhagic Telangiectasia Presenting as A Code ST Elevation Myocardial Infarction","author":"Ahmad","year":"2010"},{"key":"10.1016\/j.pupt.2021.102033_bib24","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1378\/chest.11-1402","article-title":"The intersection of genes and environment: development of pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia and stimulant exposure","volume":"141","author":"Ayala","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2021.102033_bib25","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/jmg.2010.088286","article-title":"Mosaic ACVRL1 and ENG mutations in hereditary haemorrhagic telangiectasia patients","volume":"48","author":"Best","year":"2011","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.pupt.2021.102033_bib26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s11239-015-1253-z","article-title":"Heart failure and pulmonary arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia type 2","volume":"40","author":"Du","year":"2015","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.pupt.2021.102033_bib27","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/ajmg.a.36568","article-title":"Somatic mosaicism in ACVRL1 with transmission to several offspring affected with severe pulmonary arterial hypertension","volume":"164A","author":"Jones","year":"2014","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.pupt.2021.102033_bib28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJM200108023450503","article-title":"Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia","volume":"345","author":"Trembath","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pupt.2021.102033_bib29","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/S0735-1097(17)35797-2","article-title":"Tracing the cause OF pulmonary hypertension IN hereditary hemorrhagic telangiectasia","volume":"69","author":"Nicholas Tan","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.pupt.2021.102033_bib30","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/thx.2003.11890","article-title":"Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension","volume":"59","author":"Chaouat","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2021.102033_bib31","doi-asserted-by":"crossref","first-page":"1209A","DOI":"10.1016\/j.chest.2016.08.1318","article-title":"An unusual cause of dyspnea in hereditary hemorrhagic telangiectasia","volume":"150","author":"Poh","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2021.102033_bib32","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1055\/s-2005-870835","article-title":"[Pulmonary hypertension in hereditary haemorrhagic teleangiectasia (Rendu-Osler-Weber disease). Progression over 10 years]","volume":"130","author":"Schlag","year":"2005","journal-title":"Dtsch. Med. Wochenschr."},{"key":"10.1016\/j.pupt.2021.102033_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.resinv.2013.08.003","article-title":"BMPR2 gene mutation in pulmonary arteriovenous malformation and pulmonary hypertension: a case report","volume":"52","author":"Handa","year":"2014","journal-title":"Respir Investig"},{"key":"10.1016\/j.pupt.2021.102033_bib34","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ihj.2014.09.001","article-title":"Regression of pulmonary artery hypertension due to development of a pulmonary arteriovenous malformation","volume":"66","author":"Hasan","year":"2014","journal-title":"Indian Heart J."},{"key":"10.1016\/j.pupt.2021.102033_bib35","article-title":"Diffuse pulmonary arteriovenous fistulas with pulmonary arterial hypertension: case report and review","volume":"95","author":"Jiang","year":"2016","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.pupt.2021.102033_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-226067","article-title":"Severe pulmonary hypertension associated with hepatic arteriovenous malformation in a patient with hereditary haemorrhagic telangiectasia","author":"Montrivade","year":"2018","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.pupt.2021.102033_bib37","first-page":"A6184","article-title":"Pulmonary vascular malformations in pulmonary arterial hypertension: to embolize or not?","volume":"195","author":"Matthew Moll","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2021.102033_bib38","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1183\/09031936.04.00085504","article-title":"Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia","volume":"23","author":"Abdalla","year":"2004","journal-title":"Eur. Respir. J."},{"issue":"Suppl 3","key":"10.1016\/j.pupt.2021.102033_bib39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2362.2006.01683.x","article-title":"Bosentan therapy for pulmonary arterial hypertension associated with hereditary haemorrhagic telangiectasia","volume":"36","author":"Bonderman","year":"2006","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.pupt.2021.102033_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-008352","article-title":"Pulmonary hypertension in a patient with hereditary haemorrhagic telangiectasia","author":"Chadha","year":"2013","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.pupt.2021.102033_bib41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00380-010-0079-z","article-title":"Successful bosentan therapy for pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia","volume":"26","author":"Chang","year":"2011","journal-title":"Heart Ves."},{"key":"10.1016\/j.pupt.2021.102033_bib42","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/eci.12138","article-title":"Clinical and genetic characteristics of Chinese patients with hereditary haemorrhagic telangiectasia-associated pulmonary hypertension","volume":"43","author":"Chen","year":"2013","journal-title":"Eur. J. Clin. Invest."},{"issue":"e34\u20136","key":"10.1016\/j.pupt.2021.102033_bib43","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1590\/S0066-782X2010000300026","article-title":"Hereditary hemorrhagic telangiectasia: rare cause of pulmonary hypertension?","volume":"94","author":"Providencia","year":"2010","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.pupt.2021.102033_bib44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1399-0004.2011.01727.x","article-title":"ACVRL1 germinal mosaic with two mutant alleles in hereditary hemorrhagic telangiectasia associated with pulmonary arterial hypertension","volume":"82","author":"Eyries","year":"2012","journal-title":"Clin. Genet."},{"key":"10.1016\/j.pupt.2021.102033_bib45","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1164\/rccm.200908-1284OC","article-title":"Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation","volume":"181","author":"Girerd","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2021.102033_bib46","doi-asserted-by":"crossref","DOI":"10.1177\/2045894018782664","article-title":"Different forms of pulmonary hypertension in a family with clinical and genetic evidence for hereditary hemorrhagic teleangectasia type 2","volume":"8","author":"Greco","year":"2018","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.pupt.2021.102033_bib47","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1378\/chest.06-2275","article-title":"Long-term outcome in a patient with pulmonary hypertension and hereditary hemorrhagic telangiectasia","volume":"131","author":"Minai","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2021.102033_bib48","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijcard.2016.03.211","article-title":"Pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia successfully treated with sildenafil","volume":"214","author":"Miyake","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.pupt.2021.102033_bib49","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1183\/09059180.00011113","article-title":"Fatal rupture of pulmonary arteriovenous malformation in hereditary haemorrhagic telangiectasis and severe PAH","volume":"18","author":"Montani","year":"2009","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.pupt.2021.102033_bib50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.arbres.2012.04.021","article-title":"Pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia","volume":"49","author":"Raimondi","year":"2013","journal-title":"Arch. Bronconeumol."},{"key":"10.1016\/j.pupt.2021.102033_bib51","doi-asserted-by":"crossref","DOI":"10.1177\/2045894018805406","article-title":"Treatment with low-dose tacrolimus inhibits bleeding complications in a patient with hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension","volume":"9","author":"Sommer","year":"2019","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.pupt.2021.102033_bib52","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2169\/internalmedicine.3625-19","article-title":"Pulmonary hypertension and hereditary hemorrhagic telangiectasia related to an ACVRL1 mutation","volume":"59","author":"Yokokawa","year":"2020","journal-title":"Intern. Med."},{"key":"10.1016\/j.pupt.2021.102033_bib53","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.2169\/internalmedicine.53.2850","article-title":"Pulmonary arterial hypertension as the first manifestation in a patient with hereditary hemorrhagic telangiectasia","volume":"53","author":"Ishiwata","year":"2014","journal-title":"Intern. Med."},{"key":"10.1016\/j.pupt.2021.102033_bib54","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1253\/circj.CJ-17-0299","article-title":"Thalidomide for hereditary hemorrhagic telangiectasia with pulmonary arterial hypertension","volume":"82","author":"Nakamura","year":"2018","journal-title":"Circ. J."},{"key":"10.1016\/j.pupt.2021.102033_bib55","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1752-699X.2008.00056.x","article-title":"Different features of pulmonary hypertension in Rendu-Osler Syndrome","volume":"2","author":"Ruiz-Cano","year":"2008","journal-title":"Clin. Res. J"},{"key":"10.1016\/j.pupt.2021.102033_bib56","first-page":"29","article-title":"Pulmonary hypertension in a patient with hereditary hemorrhagic telangiectasia","volume":"100","author":"Liu","year":"2017","journal-title":"R. I. Med. J."},{"key":"10.1016\/j.pupt.2021.102033_bib57","first-page":"551","article-title":"Pulmonary arterial hypertension and hereditary haemorrhagic telangiectasia","volume":"18","author":"Gilbert-Dussardier","year":"2015","journal-title":"Angiogenesis"},{"key":"10.1016\/j.pupt.2021.102033_bib58","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/jmg.40.12.865","article-title":"Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia","volume":"40","author":"Harrison","year":"2003","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.pupt.2021.102033_bib59","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2125.1982.tb01959.x","article-title":"Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man","volume":"14","author":"Pickles","year":"1982","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pupt.2021.102033_bib60","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/jmg.2005.035451","article-title":"Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia","volume":"43","author":"Letteboer","year":"2006","journal-title":"J. Med. Genet."}],"container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553921000456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553921000456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:30:39Z","timestamp":1761082239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553921000456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":60,"alternative-id":["S1094553921000456"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2021.102033","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of pulmonary hypertension in patients with Hereditary Hemorrhagic Telangiectasia \u2013 A case series and systematic review","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2021.102033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102033"}}